RecruitingNCT04451265
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Enrollment
250 participants
Start Date
Oct 26, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Patient over 18 years old
- Patient with suspected NOIA, evoked after clinical examination by a specialized ophthalmologist
- For which a brain and visual MRI is planned
- Express consent to participate in the study
- Affiliate or beneficiary of a Social Security scheme
Exclusion Criteria3
- Contraindication to MRI (electrical device, metallic foreign body, claustrophobia)
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERMRI
Diffusion sequence (8 minutes long) added to the initial MRI
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04451265